Lynx Investment Advisory’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2	Closed	-$937	–	761
2024 Q2	$937	Buy	+2	New	+$937	﹤0.01%	662